ABVC BIOPHARMA, INC. financial data

Symbol
ABVC on Nasdaq
Location
Fremont, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 03 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 40% % 24%
Debt-to-equity 106% % -73%
Return On Equity -62% % 81%
Return On Assets -34% % 41%
Operating Margin -923% % 79%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 24,301,089 shares 87%
Common Stock, Shares, Outstanding 24,190,340 shares 90%
Entity Public Float $7,200,000 USD 38%
Common Stock, Value, Issued $24,190 USD 90%
Weighted Average Number of Shares Outstanding, Basic 23,256,590 shares 87%
Weighted Average Number of Shares Outstanding, Diluted 23,256,590 shares 87%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $795,950 USD 104%
Cost of Revenue $763 USD -100%
Research and Development Expense $124,007 USD -43%
Operating Income (Loss) $4,860,962 USD -7.7%
Nonoperating Income (Expense) $475,957 USD 19%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $5,336,919 USD -4.7%
Income Tax Expense (Benefit) $527 USD 48%
Net Income (Loss) Attributable to Parent $5,077,184 USD -11%
Earnings Per Share, Basic 0 USD/shares -73%
Earnings Per Share, Diluted 0 USD/shares -73%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $192,068 USD 40%
Accounts Receivable, after Allowance for Credit Loss, Current $1,529 USD -0.06%
Inventory, Net $11,460 USD
Assets, Current $4,072,569 USD 88%
Property, Plant and Equipment, Net $12,055,642 USD 2168%
Operating Lease, Right-of-Use Asset $369,135 USD -27%
Other Assets, Noncurrent $117,017 USD
Assets $21,176,299 USD 172%
Employee-related Liabilities, Current $154,780 USD 72%
Contract with Customer, Liability, Current $81,115 USD 2%
Liabilities, Current $6,507,520 USD 4.2%
Contract with Customer, Liability, Noncurrent $296,000 USD
Operating Lease, Liability, Noncurrent $164,072 USD 15%
Liabilities $6,683,592 USD 3.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax $487,048 USD 5.6%
Retained Earnings (Accumulated Deficit) $73,295,417 USD -3.9%
Stockholders' Equity Attributable to Parent $12,057,619 USD 634%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $14,492,707 USD 984%
Liabilities and Equity $21,176,299 USD 172%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $539,833 USD 44%
Net Cash Provided by (Used in) Financing Activities $428,756 USD -54%
Common Stock, Shares Authorized 100,000,000 shares 0%
Common Stock, Shares, Issued 24,190,340 shares 90%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $104,247 USD -80%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $853,911 USD 11%
Interest Paid, Excluding Capitalized Interest, Operating Activities $5,231 USD -8.2%
Deferred Tax Assets, Valuation Allowance $6,907,870 USD 10%
Deferred Tax Assets, Gross $6,907,870 USD 10%
Operating Lease, Liability $369,135 USD -27%
Depreciation $29,960 USD 2.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $5,054,049 USD -9.6%
Lessee, Operating Lease, Liability, to be Paid $378,460 USD -26%
Property, Plant and Equipment, Gross $15,440,055 USD 37%
Operating Lease, Liability, Current $199,335 USD -45%
Lessee, Operating Lease, Liability, to be Paid, Year Two $55,613 USD -2.3%
Lessee, Operating Lease, Liability, to be Paid, Year One $118,597 USD -66%
Operating Lease, Weighted Average Discount Rate, Percent 0.03 pure 435%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $9,325 USD 632%
Lessee, Operating Lease, Liability, to be Paid, Year Three $50,888 USD
Deferred Tax Assets, Operating Loss Carryforwards $5,995,850 USD
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four $50,888 USD
Operating Lease, Payments $117,166 USD 19%
Additional Paid in Capital $93,114,989 USD 19%
Share-based Payment Arrangement, Expense $451,480 USD -50%
Interest Expense $1,438,684 USD 333%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%